Barclays »

In8bio shares owned by Barclays

Quarter-by-quarter ownership of In8bio (INAB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $39 28 1.39

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding In8bio

Alyeska Investment Group
Franklin Resources
683 Capital Management
Stonepine Capital Management
Vanguard Capital Management
BIOS Capital Management
Geode Capital Management
Citadel Advisors
Oppenheimer & Co
Vanguard Fiduciary Trust
Captrust Financial Advisors
Texas Capital Bank Wealth Management Services
Northern Trust
Renaissance Technologies
Tower Research Capital

View all funds holding In8bio